Martin J Everett

9PUBLICATIONS
26CO-AUTHORS
Plant and fungus systematics and taxonomyMedical bacteriologyPharmacogenomicsInfectious agentsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 20, 2023
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models.

Martin J Everett, David T Davies, Simon Leiris

|Apr 06, 2021
Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive Enterobacterales.

Magdalena Zalacain, Clarisse Lozano, Agustina Llanos

|Mar 31, 2021
Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria.

David T Davies, Martin Everett

|Dec 11, 2020
Discovery of ANT3310, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumannii.

David T Davies, Simon Leiris, Magdalena Zalacain

|Nov 24, 2020
Reply to Asempa et al., "The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models".

Shampa Das, Martin Everett, Magdalena Zalacain

|Aug 14, 2020
ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae.

David T Davies, Simon Leiris, Nicolas Sprynski

Pageof 2

Frequent Collaborators

5 joint publications

David T Davies

4 joint publications

Marc Lemonnier

3 joint publications

Jérôme M Castandet

3 joint publications

Thomas David Pallin